Surgical scaffolds are designed for soft tissue support and to elevate, repair, and reinforce soft tissues where voids or weakness exist.
Due to the COVID-19 pandemic, the global Surgical Scaffolds market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Surgical Scaffolds market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Surgical Scaffolds landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The surgical scaffolds market is being majorly driven by the technological development in scaffolds for restoration, replacement, and regeneration of defective organs or tissues is anticipated to propel the demand for host cell contaminant testing and drives the global market of surgical scaffolds market.
This report focuses on Surgical Scaffolds volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Surgical Scaffolds market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Surgical Scaffolds Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Bioresorbable Polymer
Human Or Animal Tissue Derived Scaffold
Silk-Derived Biological Scaffold
Others
Segment by Application
Hospitals
Diagnostic Centers
Biotechnology And Pharmaceutical Organizations
Academic & Research Institutes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Galatea Surgical
Sofregen Medical
Neotherix
Merck KGaA
Bio-Scaffold International